Metheptazine is an opioid analgesic from the phenazepane family. It was developed by American Home Products in the 1950s.[1]
![]() | |
![]() | |
Clinical data | |
---|---|
Other names | Metheptazine |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H23NO2 |
Molar mass | 261.365 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Metheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.
Metheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States.[2] The Canadian Controlled Drugs and Substances Act specifically excludes the Phenazepine opioids Metheptazine, Ethoheptazine, and Metethoheptazine from control.
References
edit- ^ US 3316244, Bell SC, Childress SJ, "Process for the preparation of hexahydro-1,3-dimethyl-4-phenylazepine-4-carboxylic acid, ethyl ester", issued 25 April 1967, assigned to American Home Products Corporation.
- ^ "Conversion Factors for Controlled Substances". U.S. Department of Justice, Drug Enforcement Administration, Diversion Control Division.